相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Georg Greiner et al.
BLOOD (2021)
Graft-versus-mastocytosis effect after donor lymphocyte infusion: Proof of principle
Hans Hagglund et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurin
Jason Gotlib et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2021)
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosis
Marcelo A. S. Toledo et al.
BLOOD (2021)
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
Tiago Azenha Rama et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
Javier Munoz-Gonzalez et al.
LANCET HAEMATOLOGY (2021)
Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management
Animesh Pardanani
AMERICAN JOURNAL OF HEMATOLOGY (2021)
COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms
Matthew P. Giannetti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis
Hanneke C. Kluin-Nelemans et al.
THERANOSTICS (2021)
The clinical and pathological panoply of systemic mastocytosis
Deepti H. Radia et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations
Ezra Y. Rosen et al.
CLINICAL CANCER RESEARCH (2020)
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S. Hong et al.
LANCET ONCOLOGY (2020)
Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis
Jeffrey W. Craig et al.
MODERN PATHOLOGY (2020)
mTOR at the nexus of nutrition, growth, ageing and disease
Grace Y. Liu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis
Karin Hartmann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
Sherly Mardiana et al.
FRONTIERS IN ONCOLOGY (2020)
An aggressive systemic mastocytosis preceded by ovarian dysgerminoma
Makiko Tsutsumi et al.
BMC CANCER (2020)
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts
Peter Valent et al.
THERANOSTICS (2020)
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants
Bryan D. Smith et al.
CANCER CELL (2019)
Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis
Jennine Grootens et al.
EBIOMEDICINE (2019)
Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis
Javier I. Munoz-Gonzalez et al.
BLOOD (2019)
MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
Mohamad Jawhar et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
CAR T cell therapy: A new era for cancer treatment
Rimjhim Mohanty et al.
ONCOLOGY REPORTS (2019)
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
Wolfgang R. Sperr et al.
LANCET HAEMATOLOGY (2019)
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis
G. Martinelli et al.
LEUKEMIA (2018)
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis
Nicole Naumann et al.
GENES CHROMOSOMES & CANCER (2018)
Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation
Reina Nagase et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Peter Valent et al.
BLOOD (2017)
Neurotrophin signalling: novel insights into mechanisms and pathophysiology
Mariela Mitre et al.
CLINICAL SCIENCE (2017)
Rictor has a pivotal role in maintaining quiescence as well as stemness of leukemia stem cells in MLL-driven leukemia
Y. Fang et al.
LEUKEMIA (2017)
Nerve growth factor: a neuroimmune crosstalk mediator for all seasons
Stephen D. Skaper
IMMUNOLOGY (2017)
Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy
Min Yang et al.
ONCOTARGET (2017)
Allogeneic NK cells eradicate myeloblasts but not neoplastic mast cells in systemic mastocytosis associated with acute myeloid leukemia
Celalettin Ustun et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
Peter Valent et al.
CANCER RESEARCH (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+advanced systemic mastocytosis
M. Jawhar et al.
LEUKEMIA (2016)
Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management
Animesh Pardanani
AMERICAN JOURNAL OF HEMATOLOGY (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice
Celalettin Ustun et al.
HAEMATOLOGICA (2016)
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
Jason Gotlib et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice
Celalettin Ustun et al.
HAEMATOLOGICA (2016)
Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management
Animesh Pardanani
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study
Andreas Hochhaus et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells
A. Pardanani et al.
LEUKEMIA (2015)
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event
M. Jawhar et al.
LEUKEMIA (2015)
Mast Cells, Mastocytosis, and Related Disorders
Theoharis C. Theoharides et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia
T. L. Lasho et al.
BLOOD CANCER JOURNAL (2015)
The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease
G. Hoermann et al.
ALLERGY (2014)
Activation of TRKB receptor in murine hematopoietic stem/progenitor cells induced mastocytosis
Min Yang et al.
BLOOD (2014)
A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection
Rosine Saleh et al.
BLOOD (2014)
A transgenic zebrafish model expressing KIT-D816V recapitulates features of aggressive systemic mastocytosis
Tugce B. Balci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Loss of Function of TET2 Cooperates with Constitutively Active KIT in Murine and Human Models of Mastocytosis
Serena De Vita et al.
PLOS ONE (2014)
Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosis
Wen-Ming Peng et al.
BLOOD (2013)
Erk1 and Erk2 are required for maintenance of hematopoietic stem cells and adult hematopoiesis
Gordon Chan et al.
BLOOD (2013)
KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis
Sigurd Broesby-Olsen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk
Karl Staser et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
State of the art paper Mastocytosis in children and adults: clinical disease heterogeneity
Magdalena Lange et al.
Archives of Medical Science (2012)
Temporal Changes in PTEN and mTORC2 Regulation of Hematopoietic Stem Cell Self-Renewal and Leukemia Suppression
Jeffrey A. Magee et al.
CELL STEM CELL (2012)
mTORC1 is essential for leukemia propagation but not stem cell self-renewal
Takayuki Hoshii et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia
Keunwook Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis
M. Niedoszytko et al.
ALLERGY (2011)
Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit
Alexander Gerbaulet et al.
BLOOD (2011)
mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells
Daniel Smrz et al.
BLOOD (2011)
Human Tryptase Cleaves Pro-Nerve Growth Factor (Pro-NGF) HINTS OF LOCAL, MAST CELL-DEPENDENT REGULATION OF NGF/PRO-NGF ACTION
Katrin Spinnler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosis
Sameer A. Parikh et al.
LEUKEMIA & LYMPHOMA (2010)
High-affinity neurotrophin receptors and ligands promote leukemogenesis
Zhixiong Li et al.
BLOOD (2009)
Unique effects of KIT D816V in BaF3 cells: Induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens
Matthias Mayerhofer et al.
JOURNAL OF IMMUNOLOGY (2008)
Activation and function of the mTORC1 pathway in mast cells
Mi-Sun Kim et al.
JOURNAL OF IMMUNOLOGY (2008)
Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, ΔTrkA
J. Meyer et al.
LEUKEMIA (2007)
Neurotrophin-3, but not nerve growth factor, promotes survival of human intestinal mast cells
A. Lorentz et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2007)
Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling
Zhifu Xiang et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders:: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients
Andres C. Garcia-Montero et al.
BLOOD (2006)
Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells
Marion Gabillot-Carre et al.
BLOOD (2006)
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Omer H. Yilmaz et al.
NATURE (2006)
Development migration, and survival of mast cells
Yoshimichi Okayama et al.
IMMUNOLOGIC RESEARCH (2006)
Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation
JP Zappulla et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Identification of mast cell progenitors in adult mice
CC Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib
C Akin et al.
BLOOD (2004)
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB
S Douma et al.
NATURE (2004)
Murine leukemia induced by retroviral gene marking
ZX Li et al.
SCIENCE (2002)
Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia
Q Liu et al.
EMBO JOURNAL (2000)
Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways
J Sawada et al.
BLOOD (2000)
分享论文
